Judann Ambrose serves as the Vice President of Marketing and Market Insights at Scholar Rock, where she leverages over 14 years of extensive experience in the biopharma industry to drive strategic marketing initiatives. As the first commercial hire at Scholar Rock, Judann has been instrumental...
Judann Ambrose serves as the Vice President of Marketing and Market Insights at Scholar Rock, where she leverages over 14 years of extensive experience in the biopharma industry to drive strategic marketing initiatives. As the first commercial hire at Scholar Rock, Judann has been instrumental in shaping the company’s marketing framework, overseeing the Global, US, Healthcare Professional (HCP), and Patient marketing teams. Her leadership has been pivotal in the commercialization of innovative therapies, particularly in the realms of rare and specialty diseases, where she has successfully launched six products, including two blockbuster drugs, across North America and Europe.
In her current role, Judann is not only responsible for marketing operations but also for the critical function of market insights, ensuring that the company remains attuned to evolving market dynamics and patient needs. Her expertise in business analysis and forecasting enables her to develop data-driven strategies that enhance product positioning and optimize market penetration. Judann’s proficiency with tools such as Siebel, Oracle, and QlikView further supports her ability to analyze complex data sets and translate insights into actionable marketing strategies.
Key projects under her leadership include the launch of groundbreaking therapies that address unmet medical needs, where she has acted as the launch lead, coordinating cross-functional teams to ensure successful market entry. Judann’s global perspective, honed through her diverse experiences across four continents, allows her to navigate the complexities of international markets effectively. Her commitment to advancing patient care through innovative marketing solutions positions her as a thought leader in the biopharma sector, driving Scholar Rock’s mission to transform the treatment landscape for patients with rare diseases.
